<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Almanac of Clinical Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Almanac of Clinical Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Альманах клинической медицины</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2072-0505</issn><issn publication-format="electronic">2587-9294</issn><publisher><publisher-name xml:lang="en">Moscow Regional Research and Clinical Institute (MONIKI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">922</article-id><article-id pub-id-type="doi">10.18786/2072-0505-2018-46-7-716-724</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Specifics of acute coronary syndrome associated with atrial fibrillation in real world clinical practice (based on the registry of the Krasnodar Region)</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности острого коронарного синдрома в сочетании с фибрилляцией предсердий в реальной клинической практике (по данным регистра Краснодарского края)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tatarintseva</surname><given-names>Z. G.</given-names></name><name xml:lang="ru"><surname>Татаринцева</surname><given-names>З. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Zoya G. Tatarintseva – </bold>MD, Head of the Cardiology Department</p><p><italic>167 1st May ul., Krasnodar, 350086</italic><italic/></p></bio><bio xml:lang="ru"><p><bold>Татаринцева Зоя Геннадьевна – </bold>заведующая кардиологическим отделением</p><p><italic>350086, г. Краснодар, ул. 1 Мая, 167</italic></p></bio><email>tatarintsev_m@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kosmacheva</surname><given-names>E. D.</given-names></name><name xml:lang="ru"><surname>Космачева</surname><given-names>Е. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Elena D. Kosmacheva – </bold>MD, PhD, Deputy Chief Physician, Scientifc Research Institute – S.V. Ochapovsky Regional Clinic Hospital No 1; Head of the Chair of Therapy No 1, Postgraduate Training Faculty, Kuban State Medical University</p><p><italic>167 1st May ul., Krasnodar, 350086, </italic></p><p><italic>4 Sedina ul., Krasnodar, 350063</italic><italic/></p></bio><bio xml:lang="ru"><p><bold>Космачева Елена Дмитриевна – </bold>доктор медицинских наук, заместитель главного врача по лечебной части, ГБУЗ «Научно-исследовательский институт – Краевая клиническая больница № 1 имени профессора С.В. Очаповского» Минздрава Краснодарского края; заведующая кафедрой терапии № 1 факультета повышения квалификации и профессиональной переподготовки специалистов, ФГБОУ ВО «Кубанский государственный медицинский университет» Минздрава России</p><p><italic>350086, г. Краснодар, ул. 1 Мая, 167, <italic> 350063, г. Краснодар, ул. Седина, 4</italic></italic></p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Raﬀ</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Рафф</surname><given-names>С. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Stanislav A. Ra</bold><bold>ﬀ</bold><bold> – </bold>MD, PhD, Chief of the Cardiology Unit No 1, Scientifc Research Institute – S.V. Ochapovsky Regional Clinic Hospital No 1; Associate Professor, Chair of Therapy No 1, Postgraduate Training Faculty, Kuban State Medical University</p><p><italic>167 1st May ul., Krasnodar, 350086, </italic></p><p><italic>4 Sedina ul., Krasnodar, 350063</italic><italic/></p></bio><bio xml:lang="ru"><p><bold>Рафф Станислав Анатольевич – </bold>кандидат медицинских наук, заведующий кардиологическим отделением №1, ГБУЗ «Научно-исследовательский институт – Краевая клиническая больница № 1 имени профессора С.В. Очаповского» Минздрава Краснодарского края; доцент кафедры терапии № 1 факультета повышения квалификации и профессиональной переподготовки специалистов, ФГБОУ ВО «Кубанский государственный медицинский университет» Минздрава России</p><p><italic>350086, г. Краснодар, ул. 1 Мая, 167, <italic> 350063, г. Краснодар, ул. Седина, 4</italic></italic></p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kruchinova</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Кручинова</surname><given-names>С. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Sofya V. Kruchinova – </bold>MD, Cardiologist, Scientifc Research Institute – S.V. Ochapovsky Regional Clinic Hospital No 1; Postgraduate Student, Chair of Therapy No 1, Postgraduate Training Faculty, Kuban State Medical University</p><p><italic>167 1st May ul., Krasnodar, 350086, </italic></p><p><italic>4 Sedina ul., Krasnodar, 350063</italic><italic/></p></bio><bio xml:lang="ru"><p><bold>Кручинова София Владимировна – </bold>врач-кардиолог, ГБУЗ «Научно-исследовательский институт – Краевая клиническая больница № 1 имени профессора С.В. Очаповского» Минздрава Краснодарского края; аспирант кафедры терапии № 1 факультета повышения квалификации и профессиональной переподготовки специалистов, ФГБОУ ВО «Кубанский государственный медицинский университет» Минздрава России</p><p><italic>350086, г. Краснодар, ул. 1 Мая, 167, <italic> 350063, г. Краснодар, ул. Седина, 4</italic></italic></p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Porkhanov</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Порханов</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Vladimir A. Porkhanov – </bold>Member of Russian Academy of Sciences, MD, PhD, Professor, Chief Physician</p><p><italic>167 1st May ul., Krasnodar, 350086</italic><italic/></p></bio><bio xml:lang="ru"><p><bold>Порханов Владимир Алексеевич – </bold>академик РАН, доктор медицинских наук, профессор, главный врач</p><p><italic>350086, г. Краснодар, ул. 1 Мая, 167</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Scientifc Research Institute – S.V. Ochapovsky Regional Clinic Hospital No 1</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Научно-исследовательский институт – Краевая клиническая больница № 1 имени профессора С.В. Очаповского» Минздрава Краснодарского края</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kuban State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Кубанский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-17" publication-format="electronic"><day>17</day><month>12</month><year>2018</year></pub-date><volume>46</volume><issue>7</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>716</fpage><lpage>724</lpage><history><date date-type="received" iso-8601-date="2018-12-14"><day>14</day><month>12</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-12-14"><day>14</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Tatarintseva Z.G., Kosmacheva E.D., Raﬀ S.A., Kruchinova S.V., Porkhanov V.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Татаринцева З.Г., Космачева Е.Д., Рафф С.А., Кручинова С.В., Порханов В.А.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Tatarintseva Z.G., Kosmacheva E.D., Raﬀ S.A., Kruchinova S.V., Porkhanov V.A.</copyright-holder><copyright-holder xml:lang="ru">Татаринцева З.Г., Космачева Е.Д., Рафф С.А., Кручинова С.В., Порханов В.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://almclinmed.ru/jour/article/view/922">https://almclinmed.ru/jour/article/view/922</self-uri><abstract xml:lang="en"><p><bold>Background: </bold>Coronary heart disease is the most common cardiovascular disorder, while atrial fibrillation (AF) is the most common heart arrhythmia.</p><p><bold>Aim: </bold>To perform a comparative analysis of the coronary substrate assessed by coronary angiography in patients with acute coronary syndrome (ACS) in combination with various AF types, as well as to analyze abnormal electrocardiographic findings and blood troponin levels in patients with ACS and AF versus ACS patients with sinus rhythm.</p><p><bold>Materials and methods: </bold>We retrospectively analyzed medical files 13,244 ACS patients entered into the total ACS registry in the Krasnodar Region from 20.11.2015 to 20.11.2017. In 1204 (9%) of them ACS was associated with AF (ACS + AF group, n = 119), the remaining 12 040 (91%) patients had sinus rhythm (ASC + SR group, n = 120).</p><p><bold>Results: </bold>Compared to the ACS + SR group, the troponin levels were significantly (р ≤ 0,05) higher in the ACS + AF group. No statistically significant diﬀerences between two groups were found for localization of hemodynamically significant coronary stenoses at coronary angiography. Only 25.0% (p = 0.1689) of patients with ACS + AF without ischemic electrocardiographic changes (ST depression or elevation) had no hemodynamically significant coronary stenoses at coronary angiography.</p><p><bold>Conclusion: </bold>AF in ACS patients is an important factor in the course of the disease and is characterized by higher blood troponin levels and significantly more frequent absence of ischemia-related electrocardiographic changes, compared to the ACS patients with sinus rhythm.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность. </bold>Ишемическая болезнь сердца – наиболее распространенное сердечно-сосудистое заболевание, тогда как фибрилляция предсердий (ФП) – наиболее распространенная сердечная аритмия.</p><p><bold>Цель – </bold>провести сравнительный анализ коронарного субстрата по данным коронароангиографии у пациентов с острым коронарным синдромом (ОКС) в сочетании с различными типами ФП, а также анализ изменений на электрокардиограмме (ЭКГ) и уровня тропонина крови у пациентов с ОКС и ФП и у пациентов с ОКС и сохранным синусовым ритмом.</p><p><bold>Материал и методы. </bold>Проведен ретроспективный анализ историй болезни 13 244 пациентов с ОКС, внесенных в тотальный регистр ОКС по Краснодарскому краю в период с 20.11.2015 по 20.11.2017. У 1204 (9%) больных течение ОКС сопровождалось ФП (группа ОКС + ФП, n = 119), у остальных 12 040 (91%) сохранялся синусовый ритм (группа ОКС + СР, n = 120).</p><p><bold>Результаты. </bold>Уровень тропонина был статистически значимо выше у пациентов из группы ОКС + ФП по сравнению с группой ОКС + СР (р ≤ 0,05); межгрупповые статистически значимые различия в локализации гемодинамически значимых стенозов в коронарных артериях по данным коронароангиографии отсутствовали. Только 25% (р = 0,1689) пациентов из группы ОКС + ФП без наличия ишемических изменений (депрессии или элевации сегмента ST) на ЭКГ не имели гемодинамически значимых стенозов в коронарных артериях по данным коронароангиографии.</p><p><bold>Заключение. </bold>ФП у пациентов с ОКС – важный фактор течения заболевания и характеризуется более высоким уровнем тропонина крови и более частым отсутствием ишемических изменений на ЭКГ по сравнению с больными ОКС с сохранным синусовым ритмом.</p></trans-abstract><kwd-group xml:lang="en"><kwd>acute coronary syndrome</kwd><kwd>registry</kwd><kwd>atrial fibrillation</kwd><kwd>coronary angiography</kwd><kwd>troponin</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>острый коронарный синдром</kwd><kwd>регистр</kwd><kwd>фибрилляция предсердий</kwd><kwd>коронароангиография</kwd><kwd>тропонин</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfsterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoﬀ N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003. doi: 10.1093/eurheartj/eht296.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P; ESC Scientifc Document Group. 2016 ESC Guidelines for the management of atrial fbrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38): 2893–962. doi: 10.1093/eurheartj/ehw210.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Голухова ЕЗ, Шумилина МВ, Кабисова АК. Ишемическое повреждение структур мозга и когнитивные нарушения у пациентов с фибрилляцией предсердий. Креативная кардиология. 2018;12(1):31–9. doi: 10.24022/1997-3187-2018-12-1-31-39.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Burokienė N, Domarkienė I, Ambrozaitytė L, Uktverytė I, Meškienė R, Karčiauskaitė D, Kasiulevičius V, Šapoka V, Kučinskas V, Kučinskienė ZA. Classical rather than genetic risk factors account for high cardiovascular disease prevalence in Lithuania: A cross-sectional population study. Adv Med Sci. 2017;62(1):121–8. doi: 10.1016/j.advms.2016.08.005.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Abidov A, Hachamovitch R, Rozanski A, Hayes SW, Santos MM, Sciammarella MG, Cohen I, Gerlach J, Friedman JD, Germano G, Berman DS. Prognostic implications of atrial fbrillation in patients undergoing myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 2004;44(5): 1062–70. doi: 10.1016/j.jacc.2004.05.076.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. AFFIRM Investigators. Atrial Fibrillation Follow-up Investigation of Rhythm Management. Baseline characteristics of patients with atrial fbrillation: the AFFIRM Study. Am Heart J. 2002;143(6):991–1001. doi: 10.1067/mhj.2002.122875.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ; ATHENA Investigators. Eﬀect of dronedarone on cardiovascular events in atrial fbrillation. N Engl J Med. 2009;360(7):668–78. doi: 10.1056/NEJMoa0803778.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Patel MR, Mahaﬀey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Caliﬀ RM; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fbrillation. N Engl J Med. 2011;365(10):883–91. doi: 10.1056/NEJMoa1009638.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fbrillation. N Engl J Med. 2009;361(12):1139–51. doi: 10.1056/NEJMoa0905561.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fbrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038–45. doi: 10.1093/eurheartj/ehn579.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Alasady M, Abhayaratna WP, Leong DP, Lim HS, Abed HS, Brooks AG, Mattchoss S, Roberts-Thomson KC, Worthley MI, Chew DP, Sanders P. Coronary artery disease aﬀecting the atrial branches is an independent determinant of atrial fbrillation after myocardial infarction. Heart Rhythm. 2011;8(7):955–60. doi: 10.1016/j.hrthm.2011.02.016.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Stenestrand U, Lindbäck J, Wallentin L; RIKSHIA Registry. Anticoagulation therapy in atrial fbrillation in combination with acute myocardial infarction inﬂuences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Circulation. 2005;112(21):3225–31.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van de Werf F, Armstrong PW, Mahaﬀey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB. Short- and long-term outcomes following atrial fbrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart. 2008;94(7):867–73. doi: 10.1136/hrt.2007.134486.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Jabre P, Jouven X, Adnet F, Thabut G, Bielinski SJ, Weston SA, Roger VL. Atrial fbrillation and death after myocardial infarction: a community study. Circulation. 2011;123(19): 2094–100. doi: 10.1161/CIRCULATIONAHA.110.990192.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141(2):190–9. doi: 10.1067/mhj.2001.112404.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Kundu A, O'Day K, Shaikh AY, Lessard DM, Saczynski JS, Yarzebski J, Darling CE, Thabet R, Akhter MW, Floyd KC, Goldberg RJ, McManus DD. Relation of atrial fbrillation in acute myocardial infarction to in-hospital complications and early hospital readmission. Am J Cardiol. 2016;117(8):1213–8. doi: 10.1016/j.amjcard.2016.01.012.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Kanjwal K, Imran N, Grubb B, Kanjwal Y. Troponin elevation in patients with various tachycardias and normal epicardial coronaries. Indian Pacing Electrophysiol J. 2008;8(3):172–4.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Tsigkas G, Kopsida G, Xanthopoulou I, Davlouros P, Koutsogiannis N, Makris G, Theodoropoulos K, Kassimis G, Gkizas V, Hahalis G, Alexopoulos D. Diagnostic accuracy of electrocardiographic ST-segment depression in patients with rapid atrial fbrillation for the prediction of coronary artery disease. Can J Cardiol. 2014;30(8):920–4. doi: 10.1016/j.cjca.2014.03.023.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Androulakis A, Aznaouridis KA, Aggeli CJ, Roussakis GN, Michaelides AP, Kartalis AN, Stougiannos PN, Dilaveris PE, Misovoulos PI, Stefanadis CI, Kallikazaros IE. Transient ST-segment depression during paroxysms of atrial fbrillation in otherwise normal individuals: relation with underlying coronary artery disease. J Am Coll Cardiol. 2007;50(19):1909–11. doi: 10.1016/j.jacc.2007.08.005.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Pradhan R, Chaudhary A, Donato AA. Predictive accuracy of ST depression during rapid atrial fbrillation on the presence of obstructive coronary artery disease. Am J Emerg Med. 2012;30(7):1042–7. doi: 10.1016/j.ajem.2011.06.027.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Matusik PT, Prior SM, Butenas S, Małecka B, Lelakowski J, Undas A. Association of cardiac troponin I with prothrombotic alterations in atrial fbrillation. Kardiol Pol. 2018;76(7):1106–9. doi: 10.5603/KP.2018.0134.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22. Elabbassi W, Chowdhury MA, Brano Liska, Hatala R. Clinical profle and angiographic fndings among patients with atrial fbrillation presenting for selective coronary angiography. Health (NY). 2014;6(1):44–50. doi: 10.4236/health.2014.61007.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alferi O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fbrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–429. doi: 10.1093/eurheartj/ehq278.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24. Shakir DK, Arafa SO. Right atrial infarction, atrial arrhythmia and inferior myocardial infarction form a missed triad: a case report and review of the literature. Can J Cardiol. 2007;23(12): 995–7. doi: 10.1016/S0828-282X(07)70864-4.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25. Lokshyn S, Mewis C, Kuhlkamp V. Atrial fbrillation in coronary artery disease. Int J Cardiol. 2000;72(2):133–6. doi: 10.1016/S0167-5273(99)00180-1.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26. Motloch LJ, Reda S, Larbig R, Wolﬀ A, Motloch KA, Wernly B, Granitz C, Lichtenauer M, Wolny M, Hoppe UC. Characteristics of coronary artery disease among patients with atrial fbrillation compared to patients with sinus rhythm. Hellenic J Cardiol. 2017;58(3):204–12. doi: 10.1016/j.hjc.2017.03.001.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G. Early and comprehensive management of atrial fbrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J. 2009;30(24):2969–77c. doi: 10.1093/eurheartj/ehp235.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28. Twerenbold R, Jaﬀe A, Reichlin T, Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J. 2012;33(5):579–86. doi: 10.1093/eurheartj/ehr492.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29. Weber M, Bazzino O, Navarro Estrada JL, de Miguel R, Salzberg S, Fuselli JJ, Liebetrau C, Woelken M, Moellmann H, Nef H, Hamm C. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J. 2011;162(1):81–8. doi: 10.1016/j.ahj.2011.04.007.</mixed-citation></ref></ref-list></back></article>
